EquityFlow › Companies › Meddenovo Drug Design

Meddenovo Drug Design

Biotech · Villeurbanne, FR

Computational drug-design company using cyclic peptides.

Funding history

DateRoundAmount
Jul 2024Pre Seed
Meddenovo Drug Design, a Villeurbanne computational-drug-design firm, raised a EUR1M pre-seed from ACT Venture Partners.
$1.1M

Investors

ACT Venture Partners

Similar companies in Biotech

ImperagenHaga BiosciencePixelgen TechnologiesGallantChai DiscoverySNIPR BiomeCellbox LabsScope BiosciencesGenLuminaActitheraNUCLIDIUMAnocca
Explore funding flow on EquityFlow →